Status: Recruiting
Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis
To evaluate the efficacy and safety of Kunxian Capsule combined with Methotrexate and Tofacitinib in the treatment of difficult-to-treat rheumatoid arthritis through a multicenter, randomized, double-blind, placebo-controlled clinical trial, and to identify the therapeutic advantages of integrated Chinese and Western medicine for optimizing the clinical strategy of D2T RA.
Participants needed: 300
Trial details
Phase: Phase 4Age: 18-70Biological sex: AllType: InterventionalSponsor: Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western MedicineUpdated: Jul 22, 2026Locations: 1
Eligibility criteria
Fully understand the purpose and requirements of the trial, voluntarily particip... [+6]
Suspected or confirmed allergy to the investigational drug (including excipients... [+31]